These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 26515103)

  • 21. Rapidity of CNS Effect on Photoparoxysmal Response for Brivaracetam vs. Levetiracetam: A Randomized, Double-blind, Crossover Trial in Photosensitive Epilepsy Patients.
    Reed RC; Rosenfeld WE; Lippmann SM; Eijkemans RMJC; Kasteleijn-Nolst Trenité DGA
    CNS Drugs; 2020 Oct; 34(10):1075-1086. PubMed ID: 32949370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Brivaracetam does not alter spatial learning and memory in both normal and amygdala-kindled rats.
    Detrait ER; Leclercq K; Löscher W; Potschka H; Niespodziany I; Hanon E; Kaminski RM; Matagne A; Lamberty Y
    Epilepsy Res; 2010 Sep; 91(1):74-83. PubMed ID: 20678901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures.
    Mumoli L; Palleria C; Gasparini S; Citraro R; Labate A; Ferlazzo E; Gambardella A; De Sarro G; Russo E
    Drug Des Devel Ther; 2015; 9():5719-25. PubMed ID: 26543353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The preclinical discovery and development of brivaracetam for the treatment of focal epilepsy.
    Russo E; Citraro R; Mula M
    Expert Opin Drug Discov; 2017 Nov; 12(11):1169-1178. PubMed ID: 28829199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and tolerability of adjunctive brivaracetam in patients with prior antiepileptic drug exposure: A post-hoc study.
    Asadi-Pooya AA; Sperling MR; Chung S; Klein P; Diaz A; Elmoufti S; Schiemann J; Whitesides J
    Epilepsy Res; 2017 Mar; 131():70-75. PubMed ID: 28279891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of Approved Drugs with Synaptic Vesicle Protein 2A.
    Danish A; Namasivayam V; Schiedel AC; Müller CE
    Arch Pharm (Weinheim); 2017 Apr; 350(3-4):. PubMed ID: 28220535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BDNF increases release probability and the size of a rapidly recycling vesicle pool within rat hippocampal excitatory synapses.
    Tyler WJ; Zhang XL; Hartman K; Winterer J; Muller W; Stanton PK; Pozzo-Miller L
    J Physiol; 2006 Aug; 574(Pt 3):787-803. PubMed ID: 16709633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postmarketing experience with brivaracetam in the treatment of epilepsies: A multicenter cohort study from Germany.
    Steinig I; von Podewils F; Möddel G; Bauer S; Klein KM; Paule E; Reif PS; Willems LM; Zöllner JP; Kunz R; Runge U; Kurlemann G; Schubert-Bast S; Rosenow F; Strzelczyk A
    Epilepsia; 2017 Jul; 58(7):1208-1216. PubMed ID: 28480518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory effects of levetiracetam on the high-voltage-activated L-type Ca²⁺ channels in hippocampal CA3 neurons of spontaneously epileptic rat (SER).
    Yan HD; Ishihara K; Seki T; Hanaya R; Kurisu K; Arita K; Serikawa T; Sasa M
    Brain Res Bull; 2013 Jan; 90():142-8. PubMed ID: 23107646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurocognitive effects of brivaracetam, levetiracetam, and lorazepam.
    Meador KJ; Gevins A; Leese PT; Otoul C; Loring DW
    Epilepsia; 2011 Feb; 52(2):264-72. PubMed ID: 20887370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Real-life experience with brivaracetam in 101 patients with difficult-to-treat epilepsy-A monocenter survey.
    Steinhoff BJ; Bacher M; Bucurenciu I; Hillenbrand B; Intravooth T; Kornmeier R; Kurth C; Stockinger J; Staack AM
    Seizure; 2017 May; 48():11-14. PubMed ID: 28364655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brivaracetam differentially affects voltage-gated sodium currents without impairing sustained repetitive firing in neurons.
    Niespodziany I; André VM; Leclère N; Hanon E; Ghisdal P; Wolff C
    CNS Neurosci Ther; 2015 Mar; 21(3):241-51. PubMed ID: 25444522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam.
    Lynch BA; Lambeng N; Nocka K; Kensel-Hammes P; Bajjalieh SM; Matagne A; Fuks B
    Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9861-6. PubMed ID: 15210974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brivaracetam prevents astroglial l-glutamate release associated with hemichannel through modulation of synaptic vesicle protein.
    Okada M; Fukuyama K; Shiroyama T; Ueda Y
    Biomed Pharmacother; 2021 Jun; 138():111462. PubMed ID: 33706129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute and long-term effects of brivaracetam and brivaracetam-diazepam combinations in an experimental model of status epilepticus.
    Niquet J; Suchomelova L; Thompson K; Klitgaard H; Matagne A; Wasterlain C
    Epilepsia; 2017 Jul; 58(7):1199-1207. PubMed ID: 28597912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First clinical postmarketing experiences in the treatment of epilepsies with brivaracetam: a retrospective observational multicentre study.
    Menzler K; Mross PM; Rosenow F; Schubert-Bast S; Willems LM; Zahnert F; Immisch I; Fuest S; von Podewils F; Kunz R; Hirsch M; Mueller T; Marquetand J; Winter Y; Langenbruch L; Cicanic M; Beyenburg S; Strzelczyk A; Knake S
    BMJ Open; 2019 Nov; 9(11):e030746. PubMed ID: 31690606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cortico-hippocampal hyperexcitability in synapsin I/II/III knockout mice: age-dependency and response to the antiepileptic drug levetiracetam.
    Boido D; Farisello P; Cesca F; Ferrea E; Valtorta F; Benfenati F; Baldelli P
    Neuroscience; 2010 Nov; 171(1):268-83. PubMed ID: 20804820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug characteristics derived from kinetic modeling: combined
    Naganawa M; Gallezot JD; Finnema SJ; Maguire RP; Mercier J; Nabulsi NB; Kervyn S; Henry S; Nicolas JM; Huang Y; Chen MK; Hannestad J; Klitgaard H; Stockis A; Carson RE
    EJNMMI Res; 2022 Nov; 12(1):71. PubMed ID: 36346513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brivaracetam: a novel antiepileptic drug for focal-onset seizures.
    Stephen LJ; Brodie MJ
    Ther Adv Neurol Disord; 2018; 11():1756285617742081. PubMed ID: 29399049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-ictogenic and antiepileptogenic properties of brivaracetam in mature and immature rats.
    Dupuis N; Matagne A; Staelens L; Dournaud P; Desnous B; Gressens P; Auvin S
    Epilepsia; 2015 May; 56(5):800-5. PubMed ID: 25818358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.